Biopharmaceutical leader in the development of treatments for rare diseases
Trans Pacific Partnership agreement with respect to data exclusivity for biologics. Education about the value of innovative new medicines.

S. 1878: "To extend the pediatric priority review voucher program". H.R.5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Educated staff about access to therapies for rare diseases in Medicaid.

Education about reimbursement for orphan drug therapies in skilled nursing facilities and proposed add-on payments in inpatient hospitals.

March 2016 CMS proposed rule implementing a new Part B drug payment model.
TRD - Trade (domestic/foreign) HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX